Clinical Trial Update: Liposomal Bupivacaine in Benign Soft Tissue Tumor Resection [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating liposomal bupivacaine for pain control after benign soft tissue tumor resection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Neoplasm
• Benign Soft Tissue Tumor

Drugs mentioned

• Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Samaritan Health Services | Conditions: Benign Neoplasm | Phase 4 | Status: UNKNOWN